Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study
Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated wit […]